These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30056565)

  • 1. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
    Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
    Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
    Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA
    Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
    Aljohani AI; Joseph C; Kurozumi S; Mohammed OJ; Miligy IM; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jun; 181(3):541-551. PubMed ID: 32350677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
    Wolf B; Goebel G; Hackl H; Fiegl H
    BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
    Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
    Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA
    Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of breast cancer pathological phenotypes.
    Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
    J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification and deletion of the RAPH1 gene in breast cancer patients.
    Batistela MS; Boberg DR; Andrade FA; Pecharki M; de S F Ribeiro EM; Cavalli IJ; Lima RS; Urban CA; Furtado-Alle L; Souza RL
    Mol Biol Rep; 2013 Dec; 40(12):6613-7. PubMed ID: 24057252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
    Karray-Chouayekh S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Gargouri A; Mokdad-Gargouri R
    Histol Histopathol; 2012 Mar; 27(3):377-85. PubMed ID: 22237715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
    Amirfallah A; Arason A; Einarsson H; Gudmundsdottir ET; Freysteinsdottir ES; Olafsdottir KA; Johannsson OT; Agnarsson BA; Barkardottir RB; Reynisdottir I
    PLoS One; 2019; 14(8):e0221413. PubMed ID: 31442252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
    Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
    Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
    Elsharawy KA; Althobiti M; Mohammed OJ; Aljohani AI; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Feb; 185(3):615-627. PubMed ID: 33161513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
    Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
    J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.